SCHEMBL4602665

SCHEMBL4602665

Cc1nc(N)sc1C([NH])=O

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.61
MAPT P10636 2/20 0.59
NPC1 O15118 4/20 0.50
RAB9A P51151 3/20 0.50
KMT2A Q03164 1/20 0.50
LCK P06239 1/20 0.49
NOS1 P29475 1/20 0.46
CYP1A2 P05177 2/20 0.43
GAA P10253 2/20 0.42
MAPK1 P28482 1/20 0.42
HPGD P15428 2/20 0.40
POLB P06746 3/20 0.40
UBE2N P61088 2/20 0.40
LMNA P02545 1/20 0.40
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
HRH2 P25021 1/20 0.38
HRH1 P35367 1/20 0.38
HRH4 Q9H3N8 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL211474 0.81 ALDH1A1 (0.63) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL179966 0.81 ALDH1A1 (0.63) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL304332 0.81 ALDH1A1 (0.63) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL21013404 0.79 ALDH1A1 (0.67) ALDH1A1MAPTNPC1RAB9AKMT2A
Hydrochloric Acid SCHEMBL27564569 0.79 ALDH1A1 (0.61) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL27564565 0.79 ALDH1A1 (0.67) ALDH1A1MAPTNPC1RAB9AKMT2A
Hydrochloric Acid SCHEMBL6239673 0.79 ALDH1A1 (0.61) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL20911243 0.78 ALDH1A1 (0.76) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL3591351 0.76 ALDH1A1 (0.58) ALDH1A1MAPTNPC1RAB9AKMT2A
SCHEMBL14373932 0.76 ALDH1A1 (0.61) ALDH1A1MAPTNPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1768978-B1 2,4,6-TRISUBSTITUTED PYRIMIDINES AS PHOSPHOTIDYLINOSITOL (PI) 3-KINASE INHIBITORS AND THEIR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2008-07-09 EP disclosed
US-20080058332-A1 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer ASTRAZENECA AB (SE) 2008-03-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080058332-A1 2,4,6-Trisubstituted Pyrimidines as Phosphotidylinositol (Pi) 3-Kinase Inhibitors and Their Use in the Treatment of Cancer PIK3CA, TYMP, PIK3CB ALDH1A1 2649/4885MAPT 3363/4885NPC1 4115/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.